TCM
UTHR icon

Twin Capital Management’s United Therapeutics UTHR Stock Holding History

Twin Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-31,540
Closed -$3.7M – 285
2019
Q1 		$3.7M Buy
31,540
+90
+0.3% +$10.5K 0.18% 160
2018
Q4 		$3.42M Sell
31,450
-580
-2% -$67.3K 0.19% 149
2018
Q3 		$4.1M Buy
32,030
+2,350
+8% +$291K 0.19% 146
2018
Q2 		$3.36M Buy
29,680
+190
+0.6% +$20.9K 0.17% 166
2018
Q1 		$3.31M Sell
29,490
-2,000
-6% -$254K 0.17% 162
2017
Q4 		$4.66M Buy
31,490
+1,150
+4% +$146K 0.23% 125
2017
Q3 		$3.56M Buy
30,340
+5,310
+21% +$678K 0.19% 165
2017
Q2 		$3.25M Sell
25,030
-18,626
-43% -$2.32M 0.19% 160
2017
Q1 		$5.91M Buy
43,656
+15,308
+54% +$2.32M 0.37% 84
2016
Q4 		$4.07M Buy
28,348
+22,798
+411% +$2.91M 0.26% 116
2016
Q3 		$655K Sell
5,550
-6,826
-55% -$820K 0.04% 300
2016
Q2 		$1.31M Buy
+12,376
New +$1.38M 0.1% 279
2015
Q2 		– Sell
-15,640
Closed -$2.7M – 266
2015
Q1 		$2.7M Buy
15,640
+3,850
+33% +$587K 0.24% 132
2014
Q4 		$1.53M Buy
11,790
+2,250
+24% +$290K 0.15% 174
2014
Q3 		$1.23M Buy
9,540
+600
+7% +$61.9K 0.12% 185
2014
Q2 		$791K Sell
8,940
-1,550
-15% -$149K 0.08% 224
2014
Q1 		$986K Sell
10,490
-1,460
-12% -$149K 0.1% 214
2013
Q4 		$1.35M Sell
11,950
-4,800
-29% -$433K 0.14% 183
2013
Q3 		$1.32M Sell
16,750
-6,200
-27% -$453K 0.14% 201
2013
Q2 		$1.51M Buy
+22,950
New +$1.48M 0.16% 166

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Twin Capital Management's UTHR Position: Q2 2019 in Review

Twin Capital Management sold out of United Therapeutics (UTHR) in Q2 2019, closing a stake of 31,540 shares — an estimated $3.7M sold.

Twin Capital Management first reported a position in UTHR in Q2 2013 and held it in 20 quarters. The position peaked at $5.91M in Q1 2017. 320 funds tracked by Wall St. Rank hold UTHR as of Q2 2019.

  • Twin Capital Management reported no remaining United Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Twin Capital Management sold 31,540 United Therapeutics shares in Q2 2019, an estimated $3.7M.
  • Twin Capital Management first reported a position in United Therapeutics in Q2 2013 and held it in 20 quarters.
  • Twin Capital Management's United Therapeutics position peaked at $5.91M in Q1 2017.
  • 320 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2019.

Based on Twin Capital Management's 13F filing for Q2 2019, filed 1 Aug 2019.